CDK5 Inhibition In�vitro and in Vivo Induces Cell Death In�myeloma and Overcomes the Obstacle of Bortezomib Resistance

International Journal of Molecular Medicine - Greece
doi 10.3892/ijmm.2020.4553
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Nelfinavir Augments Proteasome Inhibition by Bortezomib in Myeloma Cells and Overcomes Bortezomib and Carfilzomib Resistance

Blood Cancer Journal
OncologyHematology
2013English

The Hsp90 Inhibitor IPI-504 Overcomes Bortezomib Resistance in Mantle Cell Lymphoma in Vitro and in Vivo by Down-Regulation of the Prosurvival ER Chaperone BiP/Grp78

Blood
BiochemistryImmunologyCell BiologyHematology
2011English

Proteasome Inhibitors Block Myeloma-Induced Osteocyte Death in Vitro and in Vivo in Multiple Myeloma Patients

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Inhibition of Glutathione Synthesis Overcomes BCL-2-Mediated Topoisomerase Inhibitor Resistance and Induces Nonapoptotic Cell Death via Mitochondrial-Independent Pathway

Cancer Research
Cancer ResearchOncology
2006English

TRAIL/Apo2L Ligand Selectively Induces Apoptosis and Overcomes Drug Resistance in Multiple Myeloma: Therapeutic Applications

Blood
BiochemistryImmunologyCell BiologyHematology
2001English

Inhibition of BCL-xL Overcomes Polyploidy Resistance and Leads to Apoptotic Cell Death in Acute Myeloid Leukemia Cells

Oncotarget
Oncology
2015English

STK405759 as a Combination Therapy With Bortezomib or Dexamethasone, in in Vitro and in Vivo Multiple Myeloma Models

Oncotarget
Oncology
2018English

Bortezomib Induces Heme Oxygenase-1 Expression in Multiple Myeloma

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2012English

Hydroxylase Inhibition Selectively Induces Cell Death in Monocytes

Journal of Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy